1. Home
  2. PTGX vs CABO Comparison

PTGX vs CABO Comparison

Compare PTGX & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • CABO
  • Stock Information
  • Founded
  • PTGX 2006
  • CABO 1980
  • Country
  • PTGX United States
  • CABO United States
  • Employees
  • PTGX N/A
  • CABO N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • CABO Cable & Other Pay Television Services
  • Sector
  • PTGX Health Care
  • CABO Telecommunications
  • Exchange
  • PTGX Nasdaq
  • CABO Nasdaq
  • Market Cap
  • PTGX 2.8B
  • CABO 2.0B
  • IPO Year
  • PTGX 2016
  • CABO N/A
  • Fundamental
  • Price
  • PTGX $47.91
  • CABO $342.36
  • Analyst Decision
  • PTGX Strong Buy
  • CABO Hold
  • Analyst Count
  • PTGX 7
  • CABO 5
  • Target Price
  • PTGX $52.83
  • CABO $556.40
  • AVG Volume (30 Days)
  • PTGX 450.1K
  • CABO 75.9K
  • Earning Date
  • PTGX 11-08-2024
  • CABO 11-07-2024
  • Dividend Yield
  • PTGX N/A
  • CABO 3.55%
  • EPS Growth
  • PTGX N/A
  • CABO 225.28
  • EPS
  • PTGX 2.75
  • CABO 35.76
  • Revenue
  • PTGX $319,120,000.00
  • CABO $1,630,937,000.00
  • Revenue This Year
  • PTGX $400.33
  • CABO N/A
  • Revenue Next Year
  • PTGX N/A
  • CABO N/A
  • P/E Ratio
  • PTGX $17.54
  • CABO $9.30
  • Revenue Growth
  • PTGX 125.73
  • CABO N/A
  • 52 Week Low
  • PTGX $13.76
  • CABO $311.28
  • 52 Week High
  • PTGX $48.89
  • CABO $618.44
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 60.40
  • CABO 45.61
  • Support Level
  • PTGX $45.33
  • CABO $330.90
  • Resistance Level
  • PTGX $48.89
  • CABO $350.65
  • Average True Range (ATR)
  • PTGX 1.28
  • CABO 10.83
  • MACD
  • PTGX 0.11
  • CABO -0.56
  • Stochastic Oscillator
  • PTGX 77.11
  • CABO 19.18

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About CABO Cable One Inc.

Cable One Inc is a telecommunications company. It derives revenue from the provision of broadband, voice, and video services to residential and business customers. From a product perspective, the majority of revenue is sourced from data and video services. This revenue is subscription-based and billed monthly. The company also offers Sparklight TV, an internet protocol-based (IPTV) video service that allows customers with Sparklight TV app to stream video channels from the cloud. The company also derives advertising revenue from selling airtime on its video channels. Voice services are offered over Internet protocols. The company owns a telecommunications infrastructure.

Share on Social Networks: